We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Link Confirmed between Living in Poverty and Developing Diseases

By LabMedica International staff writers
Posted on 30 Sep 2019
A recently published study carried out in the United Kingdom confirmed the existence of a link between economic deprivation and the genetic tendency to develop disease.

It would seem obvious that poverty would go hand in hand with disease. More...
However, scientific proof of this linkage has been lacking. To confirm the relationship, investigators at the University of Manchester (United Kingdom) combined a test population’s Index of Multiple Deprivation Rank (IMDR) with genetic-linked health data.

The IMDR was based on multiple factors including place of residence, household income, education level, and employment status. Genetics-linked health status was based on pathogenic copy number variants (CNVs), which cause hereditary diseases due to the presence and transmission of chromosomes with extra or missing sections of DNA.

The current study included 473 families with individuals with pathogenic autosomal CNVs and known inheritance status. The participants were selected from a database of more than 17,000 DNA samples maintained by the Manchester Centre for Genomic Medicine.

Results of the analysis revealed that the IMDR distribution of families with pathogenic CNVs was significantly different from the general population. Families with inherited CNVs were significantly more likely to be living in areas of higher deprivation when compared with families that had individuals with non-inherited CNVs.

To explain the linkage between residing in areas of economic and social deprivation and the tendency to develop inherited disease, the investigators stated that, "Lower socioeconomic status in families with medically relevant inherited pathogenic and likely pathogenic [genetic changes] with milder phenotype [lower risk of disease] could therefore be due to cumulative multi-generational consequences of these subclinical effects."

The study was published in the September 23, 2019, online edition of the Journal of Medical Genetics.

Related Links:
University of Manchester


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.